Showing results (11-20 of 261) with videos related to
Sort By:
Pageof 27
Blood|January 12, 2001
Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemiaM Piron, M Loo, A Gothot, et al.Medical Oncology (Northwood, London, England)|October 24, 1998
Prediction of response to treatment with recombinant human erythropoietin in anaemia associated with cancerY BeguinBulletin Et Memoires De L'Academie Royale De Medecine De Belgique|January 1, 1993
[Quantitative measures of erythropoiesis. Soluble transferrin receptor]Y BeguinRevue Medicale De Liege|June 3, 2021
[The Arsène Burny Cancer Institute (ICAB) and its new building for the Integrated Oncology Center (CIO) at the CHU de Liège]Y BeguinHaematologica|January 1, 1992
The soluble transferrin receptor: biological aspects and clinical usefulness as quantitative measure of erythropoiesisY BeguinSeminars in Oncology|July 22, 1998
Prediction of response to optimize outcome of treatment with erythropoietinY BeguinDrug Safety|November 6, 1998
A risk-benefit assessment of epoetin in the management of anaemia associated with cancerY BeguinPageof 27